EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma
EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma
Read moreMon, 12th Oct 2020 10:06
EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma
Read moreIN BRIEF: e-Therapeutics Says Tests Underway For GalNAc-siRNA Platform
Read moreIN BRIEF: e-Therapeutics Reports Results Of Covid-19 Compounds Testing
Read moree-Therapeutics Names New Chief Executive; Plans To Ramp Up Research
Read moreIN BRIEF: e-Therapeutics Bags GBP750,000 From Retail Offer
Read moreUK WINNERS & LOSERS SUMMARY: HSBC Shares Fall Amid Investec Downgrade
Read moreIN BRIEF: e-Therapeutics Plans GBP12 Million Fundraise
Read moreUK TRADING UPDATE SUMMARY: XLMedia To Sell Finnish Casino Assets
Read more(Sharecast News) - E-therapeutics has entered a collaboration agreement with Galapagos to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF), and potentially in other fibrotic indications, it announced on Wednesday.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"
Read moreUK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor
Read moree-Therapeutics Loss Narrows On Higher Revenue And Lower R&D Spend
Read moree-Therapeutics Reshuffles Board, Issues 53.3 Million Shares
Read more